
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Pharmacists are vital in identifying at-risk patients, supporting diagnostic testing, optimizing therapy, and monitoring medication adjustments.
This FAQ was fact-checked by Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP.





